18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
about
PET/CT in Oncology: Current Status and Perspectives.Positron Emission Tomography (PET) in OncologyDetection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making.Should positron emission tomography/computed tomography be the first rather than the last test performed in the assessment of cancer?Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinomaSerum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinomaRole of Pre-therapeutic (18)F-FDG PET/CT in Guiding the Treatment Strategy and Predicting Prognosis in Patients with Esophageal Carcinoma.Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy.Maximum standardized uptake value in (18)F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer.The evolution of cancer surgery and future perspectives.Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.The role of PET-CT in radiotherapy planning of solid tumours.Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage.Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.Broncho-esophageal fistula leading to lung abscess: A life-threatening emergency detected on FDG PET/CT in a case of carcinoma of middle third esophagus.Extraesophageal saline enhances endoscopic ultrasonography to differentiate esophagus and adjacent organs.Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicine.Meta-analysis of microRNAs as potential biomarkers for detecting esophageal carcinoma in Asian populations.[New S3 guideline for esophageal cancer : Important surgical aspects].The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).Predicting tumour response to chemoradiotherapy in oesophageal cancer by early interim 18F-FDG PET: where do we stand and where should we go?To Compare and Determine the Diagnostic Accuracy of [18F]-fluorodeoxyglucose Positron Emission Tomography Scan in Predicting Pathological Response in Operated Carcinoma Esophagus Patients after Initial Neoadjuvant Chemoradiation and Neoadjuvant ChemUnderstanding the Association of Axillary Lymph Node Metastasis in Esophageal Cancers
P2860
Q33665109-7F71C33E-6BD3-4457-B6AE-F11702AC34CCQ34774840-5517BB3B-D83D-47E5-AA5B-E8CD516CC7F7Q35060966-9B610E9E-CF10-47E2-A2A6-102EEFF5011AQ35830542-4A88CA7C-55B9-4EFC-8E33-F5B3D750C58EQ36286485-192AE169-4C7C-46DF-A4EB-176B2506F6CAQ36432120-3867BD51-4907-4501-BA65-E7D15D8FC95DQ36671959-053AC5A4-9822-49C9-AC74-E4F40B8024E7Q37080068-0D119ACB-69BF-4333-BAC3-AEAF9C94A63CQ37261280-C6EB5142-C807-4287-A2D3-B0EB8F887A62Q37369075-11B7F679-85AB-4745-A870-95DFF6C0D600Q37567827-940A5C2A-266F-4768-8C4F-0CB784522619Q38266722-D41C1D70-EE56-4401-BE49-0CC3BB5B633EQ38383917-E365E961-9C8B-4D2A-BDBA-65D284969D39Q38391624-FAD2BBDF-1979-4FE0-891D-29FDD45EBD11Q38988008-5C902157-67C7-4848-8CF8-5655A7BB734AQ39043387-F49019AD-C05B-4A3A-B3FB-099D41024278Q41768209-E56FD6DC-D2E6-4FC7-9B0F-89918DA4ABD4Q41866652-2576A494-CA5B-4B33-ADD2-E51D2614A01EQ41985464-CAB0E33C-895F-411E-A740-0A8640396B21Q47108211-C08FADFD-0F0F-4FA5-8B1E-B9B641FDB640Q48139391-77CF238B-272D-46CE-9BB4-6FF6FBD9ACDBQ50236426-55CC507B-79F4-427A-9482-7EBD09841EFBQ52849942-C99D1505-CE1A-4014-A611-1BF5987B0220Q53107664-64D57149-31B3-403A-8C23-FF00C1F697F5Q53122410-9D8DB01B-18B0-4F95-8FCF-C7C5C6E992C0Q54952684-7A53587B-55C5-4A3E-A9C9-A6F77501267BQ58593251-9BE601FA-CF08-4A4E-BA52-919A10D039C0
P2860
18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@ast
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@en
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@nl
type
label
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@ast
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@en
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@nl
prefLabel
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@ast
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@en
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@nl
P2093
P1476
18F-FDG PET/CT has a high impa ...... udy with mature survival data.
@en
P2093
Cuong P Duong
Elizabeth G Drummond
Mathias Bressel
Trevor Leong
P304
P356
10.2967/JNUMED.111.101568
P407
P577
2012-05-11T00:00:00Z